MedTrace Logo

Health in Childhood Following Assisted Reproductive Technology

NCT03719703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 606

Last updated 2023-03-30

No results posted yet for this study

Summary

The purpose of this trial is to investigate the metabolic and cardiovascular health in children aged 6-8 years born after in-vitro fertilization with frozen embryo transfer

Conditions

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER

  • Anja Bisgaard Pinborg

    lead OTHER

Principal Investigators

  • Anja B. Pinborg, Prof., MD · Fertility Department, Rigshospitalet

  • Per L. Madsen, DMSc · Department of Cardiology S103, HGH

  • Rikke B. Jensen, MD, PhD · Department of Growth and Reproduction, Rigshospitalet

Eligibility

Min Age
6 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-05
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03719703 on ClinicalTrials.gov